Bisphosphonates: Effects, Uses & Side Effects
Bisphosphonates are medications used to treat bone diseases such as osteoporosis. They inhibit bone resorption and reduce the risk of fractures.
Things worth knowing about "Bisphosphonates"
Bisphosphonates are medications used to treat bone diseases such as osteoporosis. They inhibit bone resorption and reduce the risk of fractures.
What Are Bisphosphonates?
Bisphosphonates are a class of drugs that slow or inhibit the breakdown of bone tissue. They are among the most commonly prescribed medications for conditions associated with bone loss, particularly osteoporosis. Bisphosphonates bind to the mineral surface of bone and selectively interfere with the activity of bone-resorbing cells known as osteoclasts.
Indications
Bisphosphonates are used to treat a range of conditions associated with increased bone resorption or weakened bone structure:
- Osteoporosis (in postmenopausal women and in men)
- Paget's disease of bone (a disorder of abnormal bone remodeling)
- Bone metastases from cancers such as breast or prostate cancer
- Multiple myeloma (a type of bone marrow cancer)
- Hypercalcemia of malignancy (elevated blood calcium levels due to cancer)
- Long-term corticosteroid therapy (to prevent glucocorticoid-induced osteoporosis)
Mechanism of Action
Bisphosphonates mimic the structure of pyrophosphate, a naturally occurring inhibitor of bone mineralization. Once absorbed, they preferentially accumulate at sites of active bone remodeling, where they are taken up by osteoclasts. Inside these cells, bisphosphonates disrupt key metabolic pathways, ultimately triggering programmed cell death (apoptosis) of osteoclasts. This significantly reduces bone resorption while allowing bone-forming osteoblasts to continue their activity.
Two main classes are distinguished:
- Non-nitrogen-containing bisphosphonates (e.g., etidronate, clodronate): older agents with a weaker effect
- Nitrogen-containing bisphosphonates (e.g., alendronate, risedronate, ibandronate, zoledronic acid): more modern and significantly more potent agents
Dosage and Administration
Bisphosphonates can be administered orally (as tablets) or intravenously (as infusions). The dosing frequency varies depending on the specific drug:
- Daily: e.g., alendronate 10 mg/day
- Weekly: e.g., alendronate 70 mg/week
- Monthly: e.g., ibandronate 150 mg/month orally or 3 mg IV
- Yearly: e.g., zoledronic acid 5 mg as an annual infusion
When taken orally, bisphosphonates should be swallowed on an empty stomach with a full glass of plain water. The patient should remain upright (sitting or standing) for at least 30 to 60 minutes afterward to prevent irritation of the esophagus.
Side Effects
Bisphosphonates are generally well tolerated, but may cause the following side effects:
- Gastrointestinal complaints (with oral use): heartburn, difficulty swallowing, esophageal irritation or ulceration
- Flu-like symptoms (with intravenous use): fever, muscle and joint aches (typically only after the first infusion)
- Hypocalcemia: low blood calcium levels -- adequate calcium and vitamin D intake is therefore essential
- Osteonecrosis of the jaw (rare but serious complication): death of jawbone tissue, particularly associated with invasive dental procedures and higher doses
- Atypical femoral fractures (very rare): unusual stress fractures of the thigh bone after very prolonged use
- Impaired renal function (relevant with intravenous administration)
Contraindications and Precautions
Bisphosphonates are not suitable for patients with severe renal insufficiency, hypocalcemia, or esophageal disorders (when taken orally). A dental examination is recommended before starting bisphosphonate therapy. Bisphosphonates are contraindicated during pregnancy and breastfeeding.
References
- Camacho P.M. et al. - American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocrine Practice, 2020; 26(Suppl 1): 1–46.
- Russell R.G.G. et al. - Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy. Osteoporosis International, 2008; 19(6): 733–759.
- Fleisch H. - Bisphosphonates in Bone Disease: From the Laboratory to the Patient. 4th Edition. Academic Press, 2000.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryBursitis trochanterica
Sacroiliac joint syndrome
Fragility fracture
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Bisphosphonates